Amendment to Schedule 13D for Lucid Diagnostics Inc.

PAVmed Inc. filed an amendment to its Schedule 13D regarding its ownership of Lucid Diagnostics Inc. common stock. The amendment discloses that PAVmed Inc. holds 38,816,903 shares, representing 28.3% of the outstanding common stock. The filing also details the voting and dispositive power of the reporting person and its principals. Additionally, it outlines various agreements, including a Voting Agreement, Debt Exchange Agreement, Security and Pledge Agreement, Management Services Agreement, and Payroll and Benefit Expense Reimbursement Agreement, which impact the acquisition, transfer, or voting of the common stock. The amendment provides updated information on the ownership structure and the rights and obligations of the reporting person and its principals.